KEGG   PATHWAY: pleu04934
Entry
pleu04934                   Pathway                                
Name
Cushing syndrome - Peromyscus leucopus (white-footed mouse)
Description
Cushing syndrome (CS) is a rare disorder resulting from prolonged exposure to excess glucocorticoids via exogenous and endogenous sources. The typical clinical features of CS are related to hypercortisolism and include accumulation of central fat, moon facies, neuromuscular weakness, osteoporosis or bone fractures, metabolic complications, and mood changes. Traditionally, endogenous CS is classified as adrenocorticotropic hormone (ACTH)-dependent (about 80%) or ACTH- independent (about 20%). Among ACTH-dependent forms, pituitary corticotroph adenoma (Cushing's disease) is most common. Most pituitary tumors are sporadic, resulting from monoclonal expansion of a single mutated cell. Recently recurrent activating somatic driver mutations in the ubiquitin-specific protease 8 gene (USP8) were identified in almost half of corticotroph adenoma. Germline mutations in MEN1 (encoding menin), AIP (encoding aryl-hydrocarbon receptor-interacting protein), PRKAR1A (encoding cAMP-dependent protein kinase type I alpha regulatory subunit) and CDKN1B (encoding cyclin-dependent kinase inhibitor 1B; also known as p27 Kip1) have been identified in familial forms of pituitary adenomas. However, the frequency of familial pituitary adenomas is less than 5% in patients with pituitary adenomas. Among ACTH-independent CS, adrenal adenoma is most common. Rare adrenal causes of CS include primary bilateral macronodular adrenal hyperplasia (BMAH) or primary pigmented nodular adrenocortical disease (PPNAD).
Class
Human Diseases; Endocrine and metabolic disease
Pathway map
pleu04934  Cushing syndrome
pleu04934

Disease
H01431  Cushing syndrome
Organism
Peromyscus leucopus (white-footed mouse) [GN:pleu]
Gene
114680674  Plcb3; LOW QUALITY PROTEIN: 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-3 [KO:K05858] [EC:3.1.4.11]
114680691  Men1; menin isoform X1 [KO:K14970]
114681218  Cacna1h; voltage-dependent T-type calcium channel subunit alpha-1H isoform X2 [KO:K04855]
114681270  Ctnnb1; catenin beta-1 isoform X1 [KO:K02105]
114681319  Wnt7a; protein Wnt-7a [KO:K00572]
114681348  Ash2l; set1/Ash2 histone methyltransferase complex subunit ASH2 isoform X1 [KO:K14964]
114681359  Star; steroidogenic acute regulatory protein, mitochondrial [KO:K16931]
114681591  Tcf7l1; transcription factor 7-like 1 isoform X1 [KO:K04490]
114681779  Cdk2; cyclin-dependent kinase 2 isoform X1 [KO:K02206] [EC:2.7.11.22]
114682025  [KO:K04632]
114682029  [KO:K04632]
114682227  Camk2d; calcium/calmodulin-dependent protein kinase type II subunit delta isoform X1 [KO:K04515] [EC:2.7.11.17]
114682408  Arnt; aryl hydrocarbon receptor nuclear translocator isoform X1 [KO:K09097]
114682578  Rasd1; dexamethasone-induced Ras-related protein 1 [KO:K07843]
114682732  Mapk1; mitogen-activated protein kinase 1 [KO:K04371] [EC:2.7.11.24]
114682783  Nr5a1; steroidogenic factor 1 [KO:K08560]
114682816  Lef1; lymphoid enhancer-binding factor 1 isoform X1 [KO:K04492]
114682971  Wnt3a; protein Wnt-3a [KO:K00312]
114683006  Wnt9a; protein Wnt-9a [KO:K01064]
114683055  Tcf7; transcription factor 7 isoform X2 [KO:K02620]
114683299  Cacna1s; LOW QUALITY PROTEIN: voltage-dependent L-type calcium channel subunit alpha-1S [KO:K04857]
114683308  Dvl3; segment polarity protein dishevelled homolog DVL-3 isoform X1 [KO:K02353]
114684081  Apc2; LOW QUALITY PROTEIN: adenomatous polyposis coli protein 2 [KO:K02085]
114684152  Prkaca; cAMP-dependent protein kinase catalytic subunit alpha isoform X1 [KO:K04345] [EC:2.7.11.11]
114684742  [KO:K00497] [EC:1.14.15.4]
114684743  [KO:K00497] [EC:1.14.15.4]
114685753  Fzd7; frizzled-7 [KO:K02432]
114686016  Fzd9; frizzled-9 [KO:K02842]
114686204  Cacna1d; voltage-dependent L-type calcium channel subunit alpha-1D isoform X1 [KO:K04851]
114686251  Agtr1; type-1 angiotensin II receptor [KO:K04166]
114687963  Fzd1; frizzled-1 [KO:K02432]
114687991  [KO:K04374]
114688019  Wdr5b; WD repeat-containing protein 5B [KO:K14963]
114688121  Map2k2; dual specificity mitogen-activated protein kinase kinase 2 [KO:K04369] [EC:2.7.12.2]
114688126  Creb3l3; cyclic AMP-responsive element-binding protein 3-like protein 3 isoform X1 [KO:K09048]
114688160  Gna11; guanine nucleotide-binding protein subunit alpha-11 [KO:K04635]
114688199  [KO:K00070] [EC:1.1.1.145 5.3.3.1]
114688249  Cdk6; cyclin-dependent kinase 6 [KO:K02091] [EC:2.7.11.22]
114688619  [KO:K00070] [EC:1.1.1.145 5.3.3.1]
114688620  [KO:K00070] [EC:1.1.1.145 5.3.3.1]
114688621  [KO:K00070] [EC:1.1.1.145 5.3.3.1]
114688750  [KO:K00070] [EC:1.1.1.145 5.3.3.1]
114688751  [KO:K00070] [EC:1.1.1.145 5.3.3.1]
114688752  [KO:K00070] [EC:1.1.1.145 5.3.3.1]
114689707  Crhr2; corticotropin-releasing factor receptor 2 isoform X1 [KO:K04579]
114689726  Creb5; cyclic AMP-responsive element-binding protein 5 isoform X1 [KO:K09047]
114689907  Pbx1; pre-B-cell leukemia transcription factor 1 isoform X1 [KO:K09355]
114690135  Crh; corticoliberin [KO:K05256]
114690210  Mc2r; LOW QUALITY PROTEIN: adrenocorticotropic hormone receptor [KO:K04200]
114690350  [KO:K00498] [EC:1.14.15.6]
114690442  Axin2; axin-2 [KO:K04385]
114690666  Fh; fumarate hydratase, mitochondrial [KO:K01679] [EC:4.2.1.2]
114691010  Creb3l2; cyclic AMP-responsive element-binding protein 3-like protein 2 [KO:K09048]
114691187  Kmt2a; histone-lysine N-methyltransferase 2A isoform X3 [KO:K09186] [EC:2.1.1.354]
114691497  Map2k1; dual specificity mitogen-activated protein kinase kinase 1 isoform X2 [KO:K04368] [EC:2.7.12.2]
114691978  Itpr1; inositol 1,4,5-trisphosphate receptor type 1 isoform X1 [KO:K04958]
114692885  Cacna1g; voltage-dependent T-type calcium channel subunit alpha-1G isoform X1 [KO:K04854]
114693209  Dvl2; LOW QUALITY PROTEIN: segment polarity protein dishevelled homolog DVL-2 [KO:K02353]
114693311  Rap1b; ras-related protein Rap-1b [KO:K07836]
114693690  Fzd10; frizzled-10 [KO:K02842]
114693962  Adcy1; adenylate cyclase type 1 [KO:K08041] [EC:4.6.1.1]
114693978  Camk2b; calcium/calmodulin-dependent protein kinase type II subunit beta isoform X7 [KO:K04515] [EC:2.7.11.17]
114694285  Atf4; cyclic AMP-dependent transcription factor ATF-4 [KO:K04374]
114694287  Cacna1i; voltage-dependent T-type calcium channel subunit alpha-1I isoform X3 [KO:K04856]
114694498  Ccnd1; G1/S-specific cyclin-D1 isoform X2 [KO:K04503]
114694576  Ccne2; G1/S-specific cyclin-E2 isoform X1 [KO:K06626]
114694643  Pde8b; high affinity cAMP-specific and IBMX-insensitive 3',5'-cyclic phosphodiesterase 8B isoform X1 [KO:K18437] [EC:3.1.4.53]
114694717  Wnt2; protein Wnt-2 [KO:K00182]
114694793  [KO:K17767]
114695236  Ldlr; low-density lipoprotein receptor [KO:K12473]
114695609  Wnt16; protein Wnt-16 [KO:K01558]
114695763  Fzd8; frizzled-8 [KO:K02375]
114696121  Adcy2; adenylate cyclase type 2 isoform X1 [KO:K08042] [EC:4.6.1.1]
114696204  Pde8a; high affinity cAMP-specific and IBMX-insensitive 3',5'-cyclic phosphodiesterase 8A [KO:K18437] [EC:3.1.4.53]
114696574  Kcnk3; potassium channel subfamily K member 3 [KO:K04914]
114696625  Sp1; transcription factor Sp1 isoform X1 [KO:K04684]
114696655  Nr4a1; nuclear receptor subfamily 4 group A member 1 [KO:K04465]
114696710  [KO:K00512] [EC:1.14.14.19 1.14.14.32]
114696911  [KO:K04634]
114697060  Tcf7l2; transcription factor 7-like 2 isoform X1 [KO:K04491]
114697107  Adcy3; adenylate cyclase type 3 isoform X1 [KO:K08043] [EC:4.6.1.1]
114697207  Wnt4; protein Wnt-4 [KO:K00408]
114697224  E2f2; transcription factor E2F2 isoform X1 [KO:K09389]
114697442  Pomc; pro-opiomelanocortin [KO:K05228]
114697550  Nceh1; neutral cholesterol ester hydrolase 1 [KO:K14349] [EC:3.1.1.-]
114697724  Adcy8; adenylate cyclase type 8 isoform X1 [KO:K08048] [EC:4.6.1.1]
114698079  Rbbp5; retinoblastoma-binding protein 5 isoform X1 [KO:K14961]
114698218  Kcnk2; potassium channel subfamily K member 2 isoform X1 [KO:K04913]
114698264  Prkacb; cAMP-dependent protein kinase catalytic subunit beta isoform X1 [KO:K04345] [EC:2.7.11.11]
114698354  [KO:K04685]
114698355  [KO:K06621]
114698449  [KO:K22398]
114698547  [KO:K00070] [EC:1.1.1.145 5.3.3.1]
114698691  Wnt11; protein Wnt-11 isoform X1 [KO:K01384]
114698792  Rb1; retinoblastoma-associated protein isoform X1 [KO:K06618]
114698889  Ccne1; G1/S-specific cyclin-E1 isoform X1 [KO:K06626]
114699199  Wnt7b; protein Wnt-7b isoform X1 [KO:K00572]
114699390  Ahr; aryl hydrocarbon receptor [KO:K09093]
114699702  Creb3l1; cyclic AMP-responsive element-binding protein 3-like protein 1 [KO:K09048]
114699911  Fzd6; frizzled-6 [KO:K02376]
114699988  Gnai3; guanine nucleotide-binding protein G(i) subunit alpha [KO:K04630]
114700207  Camk2g; calcium/calmodulin-dependent protein kinase type II subunit gamma isoform X1 [KO:K04515] [EC:2.7.11.17]
114700757  Wnt5b; protein Wnt-5b [KO:K00444]
114700762  Cacna1c; voltage-dependent L-type calcium channel subunit alpha-1C isoform X8 [KO:K04850]
114700814  Pde11a; dual 3',5'-cyclic-AMP and -GMP phosphodiesterase 11A [KO:K13298] [EC:3.1.4.17 3.1.4.35]
114700827  Atf2; cyclic AMP-dependent transcription factor ATF-2 isoform X1 [KO:K04450]
114701050  E2f3; transcription factor E2F3 isoform X1 [KO:K06620]
114701075  [KO:K04166]
114701281  Cacna1f; voltage-dependent L-type calcium channel subunit alpha-1F [KO:K04853]
114701479  Gsk3b; glycogen synthase kinase-3 beta isoform X1 [KO:K03083] [EC:2.7.11.26]
114702113  Kcna4; potassium voltage-gated channel subfamily A member 4 [KO:K04877]
114702120  Wnt5a; protein Wnt-5a isoform X1 [KO:K00444]
114702202  Wnt9b; protein Wnt-9b [KO:K01064]
114702239  Fzd2; frizzled-2 [KO:K02235]
114702271  Wnt3; proto-oncogene Wnt-3 [KO:K00312]
114702275  Crhr1; corticotropin-releasing factor receptor 1 isoform X1 [KO:K04578]
114702796  Wdr5; WD repeat-containing protein 5 isoform X1 [KO:K14963]
114703207  Creb3; cyclic AMP-responsive element-binding protein 3 [KO:K09048]
114703666  Plcb4; 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-4 isoform X2 [KO:K05858] [EC:3.1.4.11]
114703672  Plcb1; 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1 isoform X1 [KO:K05858] [EC:3.1.4.11]
114704332  Mapk3; mitogen-activated protein kinase 3 [KO:K04371] [EC:2.7.11.24]
114704408  Armc5; armadillo repeat-containing protein 5 [KO:K22499]
114704549  Orai1; calcium release-activated calcium channel protein 1 isoform X1 [KO:K16056]
114704814  Cdk4; cyclin-dependent kinase 4 [KO:K02089] [EC:2.7.11.22]
114704841  Adcy5; LOW QUALITY PROTEIN: adenylate cyclase type 5 [KO:K08045] [EC:4.6.1.1]
114705057  Creb1; cyclic AMP-responsive element-binding protein 1 isoform X1 [KO:K05870]
114705069  Fzd5; frizzled-5 [KO:K02375]
114705120  Apc; adenomatous polyposis coli protein isoform X1 [KO:K02085]
114705144  Wnt8a; protein Wnt-8a [KO:K00714]
114705532  Egfr; epidermal growth factor receptor isoform X1 [KO:K04361] [EC:2.7.10.1]
114705847  Atf6b; cyclic AMP-dependent transcription factor ATF-6 beta isoform X1 [KO:K09049]
114705894  [KO:K00513] [EC:1.14.14.16]
114705921  Plcb2; 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2 [KO:K05858] [EC:3.1.4.11]
114706123  Itpr3; inositol 1,4,5-trisphosphate receptor type 3 [KO:K04960]
114706157  Cdkn1a; cyclin-dependent kinase inhibitor 1 [KO:K06625]
114706342  Aipl1; aryl-hydrocarbon-interacting protein-like 1 [KO:K17767]
114706541  Cdkn2c; cyclin-dependent kinase 4 inhibitor C [KO:K06622]
114706553  E2f1; LOW QUALITY PROTEIN: transcription factor E2F1 [KO:K17454]
114706830  Braf; LOW QUALITY PROTEIN: serine/threonine-protein kinase B-raf [KO:K04365] [EC:2.7.11.1]
114707150  Agt; angiotensinogen [KO:K09821]
114707256  Rap1a; ras-related protein Rap-1A [KO:K04353]
114707263  Wnt2b; protein Wnt-2b [KO:K00182]
114707293  Fzd3; frizzled-3 isoform X1 [KO:K02329]
114707396  Camk2a; LOW QUALITY PROTEIN: calcium/calmodulin-dependent protein kinase type II subunit alpha [KO:K04515] [EC:2.7.11.17]
114707907  Creb3l4; cyclic AMP-responsive element-binding protein 3-like protein 4 [KO:K09048]
114708149  Wnt8b; protein Wnt-8b [KO:K00714]
114708228  Gnai1; guanine nucleotide-binding protein G(i) subunit alpha-1 [KO:K04630]
114708251  Dvl1; segment polarity protein dishevelled homolog DVL-1 isoform X1 [KO:K02353]
114708393  Itpr2; inositol 1,4,5-trisphosphate receptor type 2 isoform X1 [KO:K04959]
114708501  Adcy7; LOW QUALITY PROTEIN: adenylate cyclase type 7 [KO:K08047] [EC:4.6.1.1]
114708522  Adcy6; adenylate cyclase type 6 isoform X1 [KO:K08046] [EC:4.6.1.1]
114708546  Wnt10b; protein Wnt-10b [KO:K01357]
114708572  Wnt1; proto-oncogene Wnt-1 [KO:K03209]
114708576  Kmt2d; histone-lysine N-methyltransferase 2D isoform X1 [KO:K09187] [EC:2.1.1.354]
114708701  Adcy4; adenylate cyclase type 4 [KO:K08044] [EC:4.6.1.1]
114709057  Usp8; ubiquitin carboxyl-terminal hydrolase 8 [KO:K11839] [EC:3.4.19.12]
114709307  Wnt10a; LOW QUALITY PROTEIN: protein Wnt-10a [KO:K01357]
114709311  Wnt6; protein Wnt-6 [KO:K00445]
114709466  Axin1; axin-1 isoform X1 [KO:K02157]
114710198  Scarb1; scavenger receptor class B member 1 isoform X1 [KO:K13885]
114710338  Cdkn1b; cyclin-dependent kinase inhibitor 1B [KO:K06624]
114710523  [KO:K04371] [EC:2.7.11.24]
114710615  Adcy9; adenylate cyclase type 9 isoform X1 [KO:K08049] [EC:4.6.1.1]
114710708  Fzd4; frizzled-4 [KO:K02354]
114710969  Gnai2; guanine nucleotide-binding protein G(i) subunit alpha-2 [KO:K04630]
Compound
C00020  AMP
C00076  Calcium cation
C00187  Cholesterol
C00238  Potassium cation
C00410  Progesterone
C00575  3',5'-Cyclic AMP
C00735  Cortisol
C01176  17alpha-Hydroxyprogesterone
C01245  D-myo-Inositol 1,4,5-trisphosphate
C01953  Pregnenolone
C05138  17alpha-Hydroxypregnenolone
C05488  11-Deoxycortisol
C07557  2,3,7,8-Tetrachlorodibenzodioxin
Reference
  Authors
Lacroix A, Feelders RA, Stratakis CA, Nieman LK
  Title
Cushing's syndrome.
  Journal
Lancet 386:913-27 (2015)
DOI:10.1016/S0140-6736(14)61375-1
Reference
  Authors
Xiong Q, Ge W
  Title
Gene mutations in Cushing's disease.
  Journal
Biomed Rep 5:277-282 (2016)
DOI:10.3892/br.2016.729
Reference
  Authors
Fukuoka H, Takahashi Y
  Title
The role of genetic and epigenetic changes in pituitary tumorigenesis.
  Journal
Neurol Med Chir (Tokyo) 54 Suppl 3:943-57 (2014)
DOI:10.2176/nmc.suppl.2014-3
Reference
  Authors
Quereda V, Malumbres M
  Title
Cell cycle control of pituitary development and disease.
  Journal
J Mol Endocrinol 42:75-86 (2009)
DOI:10.1677/JME-08-0146
Reference
  Authors
Caimari F, Korbonits M
  Title
Novel Genetic Causes of Pituitary Adenomas.
  Journal
Clin Cancer Res 22:5030-5042 (2016)
DOI:10.1158/1078-0432.CCR-16-0452
Reference
  Authors
Lecoq AL, Kamenicky P, Guiochon-Mantel A, Chanson P
  Title
Genetic mutations in sporadic pituitary adenomas--what to screen for?
  Journal
Nat Rev Endocrinol 11:43-54 (2015)
DOI:10.1038/nrendo.2014.181
Reference
  Authors
Hannah-Shmouni F, Faucz FR, Stratakis CA
  Title
Alterations of Phosphodiesterases in Adrenocortical Tumors.
  Journal
Front Endocrinol (Lausanne) 7:111 (2016)
DOI:10.3389/fendo.2016.00111
Reference
  Authors
Melmed S
  Title
Pathogenesis of pituitary tumors.
  Journal
Nat Rev Endocrinol 7:257-66 (2011)
DOI:10.1038/nrendo.2011.40
Reference
  Authors
Daly AF, Tichomirowa MA, Beckers A
  Title
Genetic, molecular and clinical features of familial isolated pituitary adenomas.
  Journal
Horm Res 71 Suppl 2:116-22 (2009)
DOI:10.1159/000192448
Reference
  Authors
Albani A, Theodoropoulou M, Reincke M
  Title
Genetics of Cushing's disease.
  Journal
Clin Endocrinol (Oxf) 88:3-12 (2018)
DOI:10.1111/cen.13457
Reference
  Authors
Duan K, Hernandez KG, Mete O
  Title
Clinicopathological correlates of adrenal Cushing's syndrome.
  Journal
Postgrad Med J 91:331-42 (2015)
DOI:10.1136/postgradmedj-2014-202612rep
Reference
  Authors
Drougat L, Espiard S, Bertherat J
  Title
Genetics of primary bilateral macronodular adrenal hyperplasia: a model for early diagnosis of Cushing's syndrome?
  Journal
Eur J Endocrinol 173:M121-31 (2015)
DOI:10.1530/EJE-15-0532
Reference
  Authors
Stratakis CA, Boikos SA
  Title
Genetics of adrenal tumors associated with Cushing's syndrome: a new classification for bilateral adrenocortical hyperplasias.
  Journal
Nat Clin Pract Endocrinol Metab 3:748-57 (2007)
DOI:10.1038/ncpendmet0648
Reference
  Authors
Refojo D, Holsboer F
  Title
CRH signaling. Molecular specificity for drug targeting in the CNS.
  Journal
Ann N Y Acad Sci 1179:106-19 (2009)
DOI:10.1111/j.1749-6632.2009.04983.x
Reference
  Authors
Kovalovsky D, Refojo D, Liberman AC, Hochbaum D, Pereda MP, Coso OA, Stalla GK, Holsboer F, Arzt E
  Title
Activation and induction of NUR77/NURR1 in corticotrophs by CRH/cAMP: involvement of calcium, protein kinase A, and MAPK pathways.
  Journal
Mol Endocrinol 16:1638-51 (2002)
DOI:10.1210/mend.16.7.0863
Reference
  Authors
Lacroix A, Baldacchino V, Bourdeau I, Hamet P, Tremblay J
  Title
Cushing's syndrome variants secondary to aberrant hormone receptors.
  Journal
Trends Endocrinol Metab 15:375-82 (2004)
DOI:10.1016/j.tem.2004.08.007
Reference
  Authors
Reincke M, Sbiera S, Hayakawa A, Theodoropoulou M, Osswald A, Beuschlein F, Meitinger T, Mizuno-Yamasaki E, Kawaguchi K, Saeki Y, Tanaka K, Wieland T, Graf E, Saeger W, Ronchi CL, Allolio B, Buchfelder M, Strom TM, Fassnacht M, Komada M
  Title
Mutations in the deubiquitinase gene USP8 cause Cushing's disease.
  Journal
Nat Genet 47:31-8 (2015)
DOI:10.1038/ng.3166
Reference
  Authors
Kaiser UB
  Title
Cushing's disease: towards precision medicine.
  Journal
Cell Res 25:649-50 (2015)
DOI:10.1038/cr.2015.53
Reference
  Authors
Uzilov AV, Cheesman KC, Fink MY, Newman LC, Pandya C, Lalazar Y, Hefti M, Fowkes M, Deikus G, Lau CY, Moe AS, Kinoshita Y, Kasai Y, Zweig M, Gupta A, Starcevic D, Mahajan M, Schadt EE, Post KD, Donovan MJ, Sebra R, Chen R, Geer EB
  Title
Identification of a novel RASD1 somatic mutation in a USP8-mutated corticotroph adenoma.
  Journal
Cold Spring Harb Mol Case Stud 3:a001602 (2017)
DOI:10.1101/mcs.a001602
Reference
  Authors
Huang C, Shi Y, Zhao Y
  Title
USP8 mutation in Cushing's disease.
  Journal
Oncotarget 6:18240-1 (2015)
DOI:10.18632/oncotarget.4856
Reference
  Authors
Theodoropoulou M, Reincke M, Fassnacht M, Komada M
  Title
Decoding the genetic basis of Cushing's disease: USP8 in the spotlight.
  Journal
Eur J Endocrinol 173:M73-83 (2015)
DOI:10.1530/EJE-15-0320
Reference
  Authors
Yu L, Zhang J, Guo X, Chen X, He Z, He Q
  Title
ARMC5 mutations in familial and sporadic primary bilateral macronodular adrenal hyperplasia.
  Journal
PLoS One 13:e0191602 (2018)
DOI:10.1371/journal.pone.0191602
Reference
  Authors
Wu X, Hua X
  Title
Menin, histone h3 methyltransferases, and regulation of cell proliferation: current knowledge and perspective.
  Journal
Curr Mol Med 8:805-15 (2008)
DOI:10.2174/156652408786733702
Reference
  Authors
Ozfirat Z, Korbonits M
  Title
AIP gene and familial isolated pituitary adenomas.
  Journal
Mol Cell Endocrinol 326:71-9 (2010)
DOI:10.1016/j.mce.2010.05.001
Related
pathway
pleu00020  Citrate cycle (TCA cycle)
pleu00140  Steroid hormone biosynthesis
pleu04020  Calcium signaling pathway
pleu04024  cAMP signaling pathway
pleu04110  Cell cycle
pleu04310  Wnt signaling pathway
pleu04927  Cortisol synthesis and secretion
pleu04960  Aldosterone-regulated sodium reabsorption
KO pathway
ko04934   

DBGET integrated database retrieval system